| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Acorn Bioventures, L.P. is a 10% Owner at OKUR. Recent filings cover 2 purchases and 0 sales. Those positions are worth an estimated $2.1M at current prices.
Acorn Bioventures, L.P.'s largest disclosed position is in OKUR as 10% Owner, worth about $2.1M. Net of sales, the recent Form 4 record there shows accumulation of 1,400,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 1,400,000 | $1.85 | $2,590,000.00 | -518.0% | +16.5% | +53.4% |